Researchers Studied Multi-Cancer Early Detection Blood Test
A large trial explored whether a blood test can improve detection rates for adults aged 50 and older.
Updated on Oct. 6, 2026 in Cancer
Live Poll
Would you choose to use a multi-cancer early detection blood test if it were available?
Researchers at the OHSU Knight Cancer Institute have investigated the effectiveness of a multi-cancer early detection blood test. The clinical trial involves more than 35,000 adults aged 50 and older across the U.S. and Canada.
Why it matters
This research addresses the significant gap in cancer screening, as current standard methods only identify 14 percent of cancer cases. Most cancers are currently diagnosed through symptomatic presentation or incidental findings rather than screening.
In a clinical trial involving over 35,000 adults aged 50 and older, researchers studied a blood test designed to detect 50 different types of cancer. While early results show promise, the diagnostic utility of the test compared to current standards remains under evaluation.
The players
OHSU Knight Cancer Institute
A research institution based in Portland, Oregon, focused on cancer prevention and early detection.
GRAIL
The manufacturer of the Galleri blood test used in the clinical study.
The details
The blood test works by identifying DNA shed by cancer cells into the bloodstream. When the test detects signals, the results indicate a specific body region to prompt further, focused diagnostic testing. This approach aims to bridge the gap in identifying cancers that currently lack standard detection methods.
Timeline
October 6, 2026: Researchers reported on the progress of the multi-cancer blood test study.
Health Landscape
This research evaluates the GRAIL Galleri test, a technology designed to supplement traditional diagnostic pathways. It marks a shift from single-cancer screening models toward broader, non-invasive early detection strategies.
If you are concerned about cancer screening, discuss which tests are appropriate for your age and health history with your physician. Current standard screenings remain the primary tool for early detection until newer diagnostic tests are fully validated.
The takeaway
This study highlights the ongoing effort to improve detection for cancers that are not currently screened for. If you have questions about which cancer screenings are recommended for your age group, bring them up during your next primary care visit.
Further reading
For more on current diagnostic advancements, visit Cancer.
Source note: This article includes information reported by KOBI-TV NBC5 / KOTI-TV NBC2.
Live Poll
Would you choose to use a multi-cancer early detection blood test if it were available?
